ID1 and hepatocellular carcinoma: In the present study, we found that high expression of ID1 promoted HCC cell proliferation and conferred oxaliplatin resistance to HCC by regulating G6PD, a key enzyme of pentose phosphate pathway, which may represent a novel target to improve the therapeutic efficacy of patients with advanced HCC.